Rapid Micro Biosystems, Inc. (RPID) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Rapid Micro Biosystems, Inc. on November 11, 2024. The report addresses a specific regulatory event regarding the Company's listing status on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing compliance event rather than financial performance.
Material Changes
The primary material change reported is the resolution of a Nasdaq listing deficiency:
- Previous Status: On February 2, 2024, the Company was notified of non-compliance with the minimum bid price requirement (Rule 5550(a)(2)) as its stock closed below $1.00 for 30 consecutive days.
- Compliance Period: The Company was granted an initial 180-day period to regain compliance, which was extended by an additional 180 days until January 27, 2025. During this time, the listing was transferred to the Nasdaq Capital Market on August 5, 2024.
- Current Status: As of November 11, 2024, the Company has regained compliance. The closing bid price of its Class A common stock was equal to or greater than $1.00 per share for ten consecutive business days.
Outlook, Risks, and Management Commentary
The Nasdaq Listing Qualifications Staff has confirmed that the matter regarding the minimum bid price requirement is now closed. The filing contains no additional management commentary, forward-looking guidance, or discussion of new risks or contingencies beyond the resolution of this specific listing issue.
Investor Verification Checklist
- Verify the current trading price of RPID on the Nasdaq Capital Market to ensure continued compliance with the $1.00 minimum bid price.
- Confirm the Company's transfer status from the Nasdaq Global Select Market to the Nasdaq Capital Market.
- Review subsequent filings for any new compliance notices or financial updates, as this 8-K contains no financial data.